Portal de Periódicos da CAPES

Subcutaneous Morphine for Dyspnea in Cancer Patients

1993; American College of Physicians; Volume: 119; Issue: 9 Linguagem: Inglês

10.7326/0003-4819-119-9-199311010-00007

1539-3704

Éduardo Bruera, Tara MacEachern, Carla Ripamonti, John Hanson,

Family and Patient Care in Intensive Care Units

Brief Reports1 November 1993Subcutaneous Morphine for Dyspnea in Cancer PatientsEduardo Bruera, MD, Tara MacEachern, RN, BScN, Carla Ripamonti, MD, and John Hanson, MScEduardo Bruera, MDFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., Tara MacEachern, RN, BScNFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., Carla Ripamonti, MDFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., and John Hanson, MScFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-119-9-199311010-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Dyspnea has been defined as an uncomfortable awareness of breathing [1]. It occurs in approximately 29% to 74% of patients with terminal cancer [2, 3] and is perceived as one of the most devastating symptoms by the patient and the family. Controlled single-dose trials have suggested that opioids are effective in the management of dyspnea associated with chronic obstructive lung disease [4]. However, opioids were poorly tolerated in these patients during repeated administration, mostly because of sedation and nausea [5]. These side effects usually disappear with the development of tolerance and are rarely a cause for discontinuing treatment among the ...References1. Wasserman K, Casaburi R. Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med. 1988; 39:503-15. Google Scholar2. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986; 89:234-6. Google Scholar3. Billings JA. Dyspnea, cough and other respiratory symptoms. In: Billings JA, ed. Outpatient Management of Advanced Cancer. Philadelphia: J.B. Lippincott; 1985:83. Google Scholar4. Woodcock AA, Gross ER, Gellert A, Shah S, Johnson M, Geddes DM. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981; 305:1611-6. Google Scholar5. Woodcock A, Gross E, Gellery A. A comparison of diazepam and promethazine in the treatment of breathlessness in patients with chronic obstructive lung disease. Br Med J. 1982; 1:96. Google Scholar6. Foley KM. The treatment of cancer pain. N Engl J Med. 1985; 313: 84-95. Google Scholar7. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990; 5:341-4. Google Scholar8. Folstein MF, Fetting JH, Lobo A, Niaz U, Capozzoli KD. Cognitive assessment of cancer patients. Cancer. 1984; 53(10 Suppl):2250-7. Google Scholar Author, Article, and Disclosure InformationAuthors: Eduardo Bruera, MD; Tara MacEachern, RN, BScN; Carla Ripamonti, MD; John Hanson, MScAffiliations: From Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy.Corresponding Author: Eduardo Bruera, MD, Edmonton General Hospital, Palliative Care Program, Room 9Y39, 11111 Jasper Avenue, Edmonton, Alberta, T5K 0L4, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySystemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational StudyPostoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelinesEffect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary DiseaseEvaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levelsDyspneaDyspneaProphylaxis and treatment of cancer-related dyspnea with pharmacologic agents: A systematic review and network meta-analysisStudy protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)Management of Dyspnea in Advanced Cancer: ASCO GuidelinePharmacologic Interventions for Breathlessness in Patients With Advanced CancerOncologic Emergencies: Palliative Care in the Emergency Department SettingEfficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled TrialsEnd-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case reportUse of short-acting opioids in the management of breathlessness: an evidence-based reviewMorphine for the symptomatic reduction of chronic breathlessness: the case for controlled releaseHow successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational studyAssociation Between Heart Rate and Reversibility of the Symptom, Refractoriness to Palliative Treatment, and Survival in Dyspneic Cancer PatientsPhysician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care PhysiciansPlace des opiacés dans le traitement de la dyspnée en soins palliatifsUnanswered questions and future direction in the management of terminal breathlessness in patients with cancerManagement of breathlessness in patients with cancer: ESMO Clinical Practice GuidelinesThe Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care PhysiciansProphylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled TrialOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illnessPalliative Care Physicians' Practice in the Titration of Parenteral Opioids for Dyspnea in Terminally Ill Cancer Patients: A Nationwide SurveyEffects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101)The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled TrialMorphine for Refractory Dyspnea in Interstitial Lung Disease: A Phase I Study (JORTC-PAL 05)Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trialSymptomatic treatment of dyspnea in advanced cancer patientsEvidence-based Palliative Care Approaches to Non-pain Physical Symptom Management in Cancer PatientsEffect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspneaEffect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled TrialRespiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysisOff-Label Medication Use in the Inpatient Palliative Care UnitManagement of Dyspnea and Central Airway Obstruction in Patients With MalignancyImpact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled TrialTreatment Recommendations for Respiratory Symptoms in Cancer Patients: Clinical Guidelines from the Japanese Society for Palliative MedicineAcupuncture for Dyspnea in Lung CancerA randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC studyContinuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia PatientsAnalgetikaEffect of fan for dyspnea in terminally ill cancer patients:Case series studyLong-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patientsOpioids prescription for symptoms relief and the impact on respiratory functionEnd of Life/Palliative Care/EthicsDyspnea, Relative Youth and Low Daily Doses of Opioids Predict Increased Opioid Dosage in the Last Week of a Terminal Cancer Patient's LifePain Management in Hospice and Palliative CareEffects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized, Controlled TrialPalliative care research: Lessons learned by our team over the last 25 yearsManagement of Non-pain Symptoms in Terminally Ill Cancer Patients: Based on National Comprehensive Cancer Network GuidelinesUtilisation du midazolam chez les patients hospitalisés : analyse des pratiques"Whatever My Mother Wants": Barriers to Adequate Pain ManagementSymptom ManagementIntegrating palliative care with intensive care for critically ill patients with lung cancerInterventions for alleviating cancer-related dyspnea: A systematic review and meta-analysisOpioids for the palliation of breathlessness in advanced disease and terminal illnessAn Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of DyspneaEvaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of ViennaComprehensive Management of Respiratory Symptoms in Patients with Advanced Lung CancerAssociation between respiratory symptoms and hydration volume in terminally ill cancer patientsA case of 'end-of-life' heart failure in a dialysis patient: Palliative care for dialysis patientsDyspnoea associated with anxiety—symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patientsUsing Laboratory Models to Test TreatmentOnce-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance StudyDyspnoea: underlying mechanisms and treatmentDyspnø hos uhelbredeligt syge og døende kræftpatienter — En systematisk litteraturgennemgang af hvilken evidens der er for lindring afdyspnø hos uhelbredeligt syge og døende kræftpatienterPalliative Care and Dyspnea Management in Patients with Hematological Malignancies and Acute Respiratory FailurePalliative Care in the Management of Cancer PainAdministration des médicaments par voie sous-cutanée en soins palliatifsManagement of dyspnea in older adults with cancerDoes the Use of a Handheld Fan Improve Chronic Dyspnea? A Randomized, Controlled, Crossover TrialOpioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patientsImpact of a pediatric palliative care programPalliative Care for Patients with Lung CancerManagement of dyspnea in patients with chronic obstructive pulmonary diseaseUse of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective studyPalliative care for patients with respiratory diseases and critical illnessesAdvanced Lung Disease: Quality of Life and Role of Palliative CareManagement of DyspneaPalliative Care in Pediatric OncologySymptom Management in Children with CancerManagement of Dyspnea in Cancer PatientsOpioids and Infections in the Intensive Care Unit Should Clinicians and Patients be Concerned?The symptomatic relief of dyspneaTreating Distress at the End of LifeInterventions for Alleviating Cancer-Related Dyspnea: A Systematic ReviewOral Transmucosal Fentanyl Citrate for Dyspnea in Terminally Ill Patients: An Observational Case SeriesMorphine in the management of dyspnoea in ALS. A pilot studyAn Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical IllnessesThe management of dyspnea in cancer patients: a systematic reviewEnd-of-Life CareIs There a Higher Risk of Respiratory Depression in Opioid-Naïve Palliative Care Patients during Symptomatic Therapy of Dyspnea with Strong Opioids?Evidence for Improving Palliative Care at the End of Life: A Systematic ReviewKarl A. Lorenz, MD, MSHS, Joanne Lynn, MD, MA, MS, Sydney M. Dy, MD, Lisa R. Shugarman, PhD, Anne Wilkinson, MS, PhD, Richard A. Mularski, MD, MSHS, MCR, Sally C. Morton, PhD, Ronda G. Hughes, RN, MHS, PhD, Lara K. Hilton, BA, Margaret Maglione, PhD, Shannon L. Rhodes, MS, Cony Rolon, BA, Virginia C. Sun, BS, MSN, and Paul G. Shekelle, MD, PhDEffect of hydromorphone on ventilation in palliative care patients with dyspneaThe National Agenda for Quality Palliative Care: Promoting the National Consensus Project's Domain of Physical Care and the National Quality Forum's Preferred Practices for Physical Aspects of CareHigh-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airwayThe evidence base of palliative medicine: is inpatient palliative medicine evidence-based?Pharmacological management of dyspnoeaSymptomatic Therapy of Dyspnea with Strong Opioids and Its Effect on Ventilation in Palliative Care PatientsPalliative Care in the Management of Cancer PainEthical and Practical Issues with Opioids in Life-Limiting IllnessA case of successful treatment with a combination of morphine and a fentanyl patch in a patient suffering from cancer pain accompanied by coughing and dyspneaA Randomized, Double-Blind, Crossover Trial of the Effect of Oxygen on Dyspnea in Patients with Advanced CancerPalliative care and paediatric respiratory medicineAuthor's ResponsePalliative management of refractory dyspnea in COPDSymptom Control in Palliative Care—Part III: Dyspnea and DeliriumPalliative Care and PediatricsThe Care of the Terminal PatientComprehensive Symptom Management in Patients with Advanced-Stage Non–Small-Cell Lung CancerDyspnea Management in Lung Cancer: Applying the Evidence From Chronic Obstructive Pulmonary DiseaseDyspnoe bei Kindern und Jugendlichen in der PalliativphaseNebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary StudyBehandlung von Luftnot bei fortgeschrittenen TumorerkrankungenPrise en charge pharmacologique de la dyspnée chez le patient atteint d'un cancer avancéControl of common, non-pain cancer symptomsA Systematic Review of Oxygen and Airflow Effect on Relief of Dyspnea at Rest in Patients with Advanced Disease of Any CauseSymptom management in the older adultMorphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?Jewish Medical Ethics and End-of-Life CareTraitement de la dyspnée en fin de vieChallenges for Palliative Care ResearchContinuous Subcutaneous Infusion of Opiates at End-of-LifeManaging respiratory symptoms at the end of lifeCare Near the End of LifePalliative Care in the Terminal Stage of Neurological DiseasesEnd-of-Life Care in Patients With Lung Cancer*Ensuring competency in end-of-life care: controlling symptomsCaring for children with advanced cancerCaring for the Dying Patient With Lung CancerManaging dyspnea and coughClinical management of dyspnoeaManagement of Dyspnea at The End of Life: Relief for Patients and SurgeonsNebulized Furosemide as a Novel Treatment for Dyspnea in Terminal Cancer PatientsDyspnea: Recognizing and Managing an Invisible ProblemPalliative Medicine - Tutorial-Part 1Inpatient palliative medicine is evidence basedOpioids for the palliation of breathlessness in advanced disease and terminal illness.Management of emergent conditions in palliative carePharmacologic Management of Nonpain Symptoms in Surgical PatientsNebulized hydromorphone for dyspnea in hospice care of advanced cancerDyspnea assessment and management in hospice patients with pulmonary disordersManagement of Dyspnea in Severe Chronic Obstructive Pulmonary DiseaseCase Discussions in Palliative MedicineDyspnea in Palliative Care PatientsThe effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trialSymptom Control in Hospice – State of the ArtHow Effective Are Supplementary Doses of Opioids for Dyspnea in Terminally Ill Cancer Patients? A Randomized Continuous Sequential Clinical TrialPalliation of breathlessnessSupportive Treatment in the Management of Lung CancerThe palliation of dyspnea in terminal diseaseNebulized Morphine for the Treatment of Dyspnea in Cancer PatientsDyspnoea in patients with advanced cancer: Incidence, causes and treatmentsAlleviation of Dyspnea in Patients with Advanced Cancer: Usefulness of OpioidADVANCED LUNG DISEASEEnd-of-Life Care in Cystic FibrosisDyspnea: Assessment and treatmentSymptomatic Management of the Older Person with CancerCare Near the End of LifePain and Symptom Management in Palliative CarePSYCHIATRIC EMERGENCIES IN TERMINALLY ILL CANCER PATIENTSThe Disposition of Morphine and Its 3- and 6-Glucuronide Metabolites in Humans and Animals, and the Importance of the Metabolites to the Pharmacological Effects of MorphinePalliative care in EdmontonEthical dilemmas in hospice and palliative careIndicators of Quality Medical Care for the Terminally Ill in Nursing Homes2 Ausgewählte medizinische, pflegerische und psychosoziale Aspekte bei der Versorgung und Betreuung von Tumorkranken in der Finalphase 1 November 1993Volume 119, Issue 9 Page: 906-907 Keywords Cancer treatment Dyspnea Lungs Morphine Opioids Oxygen Respiratory rate Sedation Subcutaneous injections Visual analog scale ePublished: 15 August 2000 Issue Published: 1 November 1993 Copyright & PermissionsCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...